Advertisement
Advertisement
U.S. Markets open in 3 hrs 18 mins
Advertisement
Advertisement
Advertisement
Advertisement

Vertex Pharmaceuticals Incorporated (VRTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
Visitors trend2W10W9M
295.77-3.06 (-1.02%)
At close: 04:00PM EDT
293.70 -2.07 (-0.70%)
Pre-Market: 05:07AM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 8/11/2022
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.49
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 3301.80
52 Week Low 3176.36
50-Day Moving Average 3278.79
200-Day Moving Average 3244.39

Share Statistics

Avg Vol (3 month) 31.63M
Avg Vol (10 day) 31.61M
Shares Outstanding 5254.25M
Implied Shares Outstanding 6N/A
Float 8255.13M
% Held by Insiders 10.25%
% Held by Institutions 194.14%
Shares Short (Jul 14, 2022) 43.59M
Short Ratio (Jul 14, 2022) 41.94
Short % of Float (Jul 14, 2022) 41.41%
Short % of Shares Outstanding (Jul 14, 2022) 41.40%
Shares Short (prior month Jun 14, 2022) 43.42M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 22:1
Last Split Date 3Aug 23, 2000

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin 30.84%
Operating Margin (ttm)36.85%

Management Effectiveness

Return on Assets (ttm)13.88%
Return on Equity (ttm)24.65%

Income Statement

Revenue (ttm)7.95B
Revenue Per Share (ttm)30.97
Quarterly Revenue Growth (yoy)21.60%
Gross Profit (ttm)3.62B
EBITDA 3.06B
Net Income Avi to Common (ttm)2.45B
Diluted EPS (ttm)8.34
Quarterly Earnings Growth (yoy)16.70%

Balance Sheet

Total Cash (mrq)8.24B
Total Cash Per Share (mrq)32.21
Total Debt (mrq)872.5M
Total Debt/Equity (mrq)8.00
Current Ratio (mrq)4.75
Book Value Per Share (mrq)37.20

Cash Flow Statement

Operating Cash Flow (ttm)2.68B
Levered Free Cash Flow (ttm)1.88B
Advertisement
Advertisement